As of 2024-12-13, the EV/EBITDA ratio of Shockwave Medical Inc (SWAV) is
67.60.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SWAV's latest enterprise value
is 13,017.65 mil USD. SWAV's TTM EBITDA according to its financial statements is
192.56 mil USD. Dividing these 2
quantities gives us the above SWAV EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
14.7x - 16.8x |
16.3x |
| Forward P/E multiples |
20.1x - 23.2x |
20.4x |
| Fair Price |
63.38 - 165.08 |
107.59 |
| Upside |
-81.1% - -50.7% |
-67.9% |